OACC · Oaktree Acquisition Corp. III Life Sciences
$10.74
-0.03 (-0.28%)
At close · Aug 19
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Such potential liquidity shortfalls and mandatory liquidation condition raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$264.26M
Shares
24.58M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.74
Open$10.75
Day$10.74–10.79
52W close$10.39–10.80
Avg vol 30d44K
Short int10K · 0.0% float · 1.0d
Short vol8%
DataDec 2024–Aug 2026
Filing10-Q · Aug 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+1%
above
Price vs 50-day avg
+1%
above
RSI (14)
54
neutral
MACD trend
Positive
52-week position
85%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+1%
trailing
YTD return
+2%
this year
Relative strength
−10%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $11 — 50d above 200d
Institutional flow
Distributing
-3% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.04% of float · ▼ -17.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
56 holders — mid 1-yr range
Squeeze score
27
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
6%
annualized · 1-yr
Max drawdown
−3%
past year
ATR
0.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+1%
Bullish
Price vs 50-day avg
+1%
Bullish
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
85%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $11 › 200d $11 — 50d above 200d
Institutional flow
Distributing
-3% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.04% of float · ▼ -17.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
56 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $10
Now $11 · 85%
Range high $11
vs 200-day avg +1%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OACC
this stock
Oaktree Acquisition Corp. III Life Sciences
|
$264.26M | +1.5% | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
CCXI
Churchill Capital Corp XI
|
$811.55M | — | — | — | 3.8% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$645.92M | +2.4% | — | — | 0.2% |
|
BCSS
Bain Capital GSS Investment Corp.
|
$600.35M | +2.0% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OACC | +0.0% | +0.4% | +1.3% | +0.0% | +1.5% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | +0.4% | -2.5% | -10.3% | -3.0% | -11.3% |